Skip to main content
. 2020 Mar 13;21(6):1969. doi: 10.3390/ijms21061969
ATI amylase trypsin inhibitor
AUC area under the curve
DE differentially expressed
FDR false discovery rate
FODMAPs fermentable oligo-, di-, monosaccharides
HLA human leukocyte antigen
IBS irritable bowel syndrome
IPA ingenuity pathway analysis
LASSO least absolute shrinkage and selection operator
lncRNA long non-coding RNA
LPS lipopolysaccharide
NCWS non-celiac wheat sensitivity
PCA principal component analysis
SIBO small intestinal bacterial overgrowth